Lee's Pharmaceutical HoldingsLPCUF 72 PB Ratio is 0.43 as of Jul. 08, 2026, which is 58% below its 10-year median of 1.03. GuruFocus rates LPCUF with a GF Score™ of 72/100 and a GF Value™ of $0.30. The stock has 5 warning signs investors should review. Among 919 Drug Manufacturers companies, Lee's Pharmaceutical Holdings ranks better than 96.74% on this metric.
Lee's Pharmaceutical Holdings Ltd stock PB Ratio (=0.3) is close to 10-year low of 0.3.
The historical rank and industry rank for Lee's Pharmaceutical Holdings's PB Ratio or its related term are showing as below:
LPCUF'
s PB Ratio Range Over the Past 10 Years
Min: 0.3 Med: 1.03 Max: 4.42
Current: 0.3
During the past 13 years, Lee's Pharmaceutical Holdings's highest PB Ratio was 4.42. The lowest was 0.30. And the median was 1.03.
LPCUF's PB Ratio is ranked better than 96.74% of 919
companies
in the Drug Manufacturers industry
Industry Median: 1.91
vs LPCUF: 0.30
During the past 12 months, Lee's Pharmaceutical Holdings's average Book Value Per Share Growth Rate was 23.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -3.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 1.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Lee's Pharmaceutical Holdings was 94.50% per year. The lowest was -12.50% per year. And the median was 17.75% per year.
Back to Basics: PB Ratio
Lee's Pharmaceutical Holdings (OTCPK:LPCUF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Lee's Pharmaceutical Holdings PB Ratio Related Terms
Lee's Pharmaceutical Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lee's Pharmaceutical Holdings PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Lee's Pharmaceutical Holdings's PB Ratio falls into.
Lee's Pharmaceutical Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Lee's Pharmaceutical Holdings (LPCUF) has a PB Ratio of 0.43 as of Jul. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Lee's Pharmaceutical Holdings and its competitors. This is 58% below median its historical median of 1.03. Over the past decade, Lee's Pharmaceutical Holdings' PB Ratio has ranged from 0.30 to 4.42. According to the industry distribution chart, Lee's Pharmaceutical Holdings ranks #30 out of 919 companies in the Drug Manufacturers industry, placing it in the top 3.3%.
Is Lee's Pharmaceutical Holdings' PB Ratio too high?
Lee's Pharmaceutical Holdings' current PB Ratio of 0.43 is 58% below median its 10-year median of 1.03. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 4.42. The Drug Manufacturers industry median PB Ratio is 1.91. Lee's Pharmaceutical Holdings' value of 0.43 is 77.5% below this industry median. Based on the distribution chart, Lee's Pharmaceutical Holdings ranks #30 out of 919 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Lee's Pharmaceutical Holdings has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Lee's Pharmaceutical Holdings' PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Lee's Pharmaceutical Holdings ranks #30 out of 919 companies for PB Ratio. This places Lee's Pharmaceutical Holdings in the top 3% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.91. Lee's Pharmaceutical Holdings' value of 0.43 is 77.5% below this benchmark. Historically, Lee's Pharmaceutical Holdings' own PB Ratio has ranged from 0.30 to 4.42 over the past decade. While the company's 10-year median is 1.03 vs. the industry median of 1.91, Lee's Pharmaceutical Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.91, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lee's Pharmaceutical Holdings's current PB Ratio of 0.43 is 77.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Lee's Pharmaceutical Holdings and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lee's Pharmaceutical Holdings's current PB Ratio is 0.43, which is 58% below median its own 10-year median of 1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lee's Pharmaceutical Holdings stock overvalued right now?
Lee's Pharmaceutical Holdings (LPCUF) has a current PB Ratio of 0.43. The stock's GF Value™ is $0.30, compared to a current price of $0.19 — trading 36.6% below its estimated fair value. The current PB Ratio is 0.43, which is 58% below median its 10-year median of 1.03 and 77.5% below the Drug Manufacturers industry median of 1.91. Lee's Pharmaceutical Holdings' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Lee's Pharmaceutical Holdings (LPCUF), the current PB Ratio is 0.43 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lee's Pharmaceutical Holdings (LPCUF) Overvalued in 2026?
Based on GuruFocus' analysis, Lee's Pharmaceutical Holdings stock appears to be undervalued.
The current stock price of $0.19 is trading 36.6% below its estimated GF Value™ of $0.30.
Key valuation signals for LPCUF:
PB Ratio: 0.43 (58% below median its 10-year median of 1.03)
GF Value™: $0.30 vs. price of $0.19 (36.6% below fair value)
Industry Position: 77.5% below the Drug Manufacturers median (#30 of 919)
No single metric tells the full story. See the LPCUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lee's Pharmaceutical Holdings Business Description
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue; and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.
72GF Score
Get the complete analysis for LPCUF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LPCUF has been successfully added to your 
